Novel Pilot Clinical Trials For ALS Based on Disease Biomarkers
The ALS Association together with the ALS Finding a Cure Foundation recently announced a $3 million funding for…
Articles by Patrícia Silva, PhD
Genervon Filed Patent for GM604 As A Promising Therapeutic Strategy for ALS
Genervon Biopharmaceuticals recently announced it has filed a patent application based on data from the Phase 2A clinical trial…
Novel Insights Into Neurodegenerative Diseases Linked to TDP-43
Researchers at the University of California at San Francisco (UCSF) recently revealed new insights into the pathogenesis of neurodegenerative…
ALS Association Reveals New Insights Into a Protein Linked to ALS
The ALS (amyotrophic lateral sclerosis) Association revealed that a team of researchers funded by the Association and led by…
Researchers Discover Immune System Plays a Critical Role in ALS Development
Researchers at CRCHUM and the University of Montreal in Canada discovered a previously unknown link between amyotrophic lateral sclerosis…
New Insights Into Molecular Mechanisms Underlying Neurodegenerative Diseases – HSAN II and ALS
Dr. Ivan Dikic at Goethe University, Frankfurt, Germany has been involved in two groundbreaking studies focusing on molecular details underlying neurodegenerative…
Key Cellular Pathway Offers a New Therapeutic Target for ALS
A new study recently published in the journal PNAS revealed that a new cellular mechanism involving a…
Promising Pioneering Injectable Electronics in the Field of Neurodegenerative Diseases, ALS
A new study entitled “Syringe-injectable electronics” recently published in the journal Nature Nanotechnology revealed…
Q Therapeutics Announces FDA Clearance of Its Stem Cell Therapy Q-Cells for Human Trials in ALS
Q Therapeutics, Inc., a company focused on adult stem cell therapies for disorders of the central nervous system, recently…
Sigma-Aldrich Collaborates With XCell Science to Advance Research in Neurological Diseases
Sigma-Aldrich Corporation recently announced it has established an agreement with XCell Science to launch genetically engineered human neural…